Entries of Volkenandt, Matthias on the publication server
![]() | Up a level |
Number of items: 6.
2011
Ziefle, Susanne, Egberts, Friederike, Heinze, Sarah, Volkenandt, Matthias, Schmid-Wendtner, Monika, Tilgen, Wolfgang, Linse, Ruthild, Boettjer, Jörg, Vogt, Thomas, Spieth, Konstanze, Eigentler, Thomas
, Brockmeyer, Norbert H., Heinz, Andreas, Hauschild, Axel and Schaefer, Martin
(2011)
Health-related Quality of Life Before and During Adjuvant Interferon-α Treatment for Patients With Malignant Melanoma (DeCOG-Trial).
Journal of Immunotherapy 34 (4), pp. 403-408.
Fulltext not available.
, Brockmeyer, Norbert H., Heinz, Andreas, Hauschild, Axel and Schaefer, Martin
(2011)
Health-related Quality of Life Before and During Adjuvant Interferon-α Treatment for Patients With Malignant Melanoma (DeCOG-Trial).
Journal of Immunotherapy 34 (4), pp. 403-408.
Fulltext not available.
2010
Heinze, Sarah, Egberts, Friederike, Rötzer, Susanne, Volkenandt, Matthias, Tilgen, Wolfgang, Linse, Ruthild, Boettjer, Jörg, Vogt, Thomas, Spieth, Konstanze, Eigentler, Thomas
, Brockmeyer, Norbert H., Hinzpeter, Axel, Hauschild, Axel and Schaefer, Martin
(2010)
Depressive Mood Changes and Psychiatric Symptoms During 12-month Low-dose Interferon-α Treatment in Patients With Malignant Melanoma.
Journal of Immunotherapy 33 (1), pp. 106-114.
Fulltext not available.
, Brockmeyer, Norbert H., Hinzpeter, Axel, Hauschild, Axel and Schaefer, Martin
(2010)
Depressive Mood Changes and Psychiatric Symptoms During 12-month Low-dose Interferon-α Treatment in Patients With Malignant Melanoma.
Journal of Immunotherapy 33 (1), pp. 106-114.
Fulltext not available.
2009
Hauschild, Axel, Weichenthal, Michael, Rass, Knuth, Linse, Ruthild, Ulrich, Jens, Stadler, Rudolf, Volkenandt, Matthias, Grabbe, Stephan, Proske, Ulrike, Schadendorf, Dirk, Brockmeyer, Norbert, Vogt, Thomas, Rompel, Rainer, Kaufmann, Roland, Kaatz, Martin, Näher, Helmut, Mohr, Peter, Eigentler, Thomas
, Livingstone, Elisabeth and Garbe, Claus
(2009)
Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma.
Journal of Clinical Oncology 27 (21), pp. 3496-3502.
Fulltext not available.
, Livingstone, Elisabeth and Garbe, Claus
(2009)
Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma.
Journal of Clinical Oncology 27 (21), pp. 3496-3502.
Fulltext not available.
2008
Garbe, Claus, Hauschild, Axel, Volkenandt, Matthias, Schadendorf, Dirk, Stolz, Wilhelm, Reinhold, Uwe, Kortmann, Rolf-Dieter, Kettelhack, Christoph, Frerich, Bernhard, Keilholz, Ulrich, Dummer, Reinhard, Sebastian, Günther, Tilgen, Wolfgang, Schuler, Gerold, Mackensen, Andreas and Kaufmann, Roland
(2008)
Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma.
Melanoma Research 18 (1), pp. 61-67.
Fulltext not available.
Garbe, Claus, Hauschild, Axel, Volkenandt, Matthias, Schadendorf, Dirk, Stolz, Wilhelm, Reinhold, Uwe, Kortmann, Rolf-Dieter, Kettelhack, Christoph, Frerich, Bernhard, Keilholz, Ulrich, Dummer, Reinhard, Sebastian, Günther, Tilgen, Wolfgang, Schuler, Gerold, Mackensen, Andreas and Kaufmann, Roland
(2008)
Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
Melanoma Research 18 (2), pp. 152-160.
Fulltext not available.
2007
Garbe, Claus, Hauschild, Axel, Volkenandt, Matthias, Schadendorf, Dirk, Stolz, Wilhelm, Reinhold, Uwe, Kortmann, Rolf-Dieter, Kettelhack, Christoph, Frerich, Bernhard, Keilholz, Ulrich, Dummer, Reinhard, Sebastian, Günther, Tilgen, Wolfgang, Schuler, Gerold, Mackensen, Andreas and Kaufmann, Roland
(2007)
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Melanoma Research 17 (6), pp. 393-399.
Fulltext not available.
